Selected research
Industry Growth & Trends
Global Transdermal Skin Patches Industry Growth and Trends Forecast to 2032
Market perspective
The global Transdermal Skin Patches market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Transdermal Skin Patches is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Transdermal Skin Patches is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Transdermal Skin Patches is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Transdermal Skin Patches include Hisamitsu Pharmaceutical, Luye Pharma Group, Mundipharma International, Purdue Pharma, Mylan N.V., Novartis AG, Johnson & Johnson and Teva Pharmaceutical Industries, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Transdermal Skin Patches market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Transdermal Skin Patches market size, estimates, and forecasts are presented in terms of sales volume (M Pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Transdermal Skin Patches market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Transdermal Skin Patches.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Transdermal Skin Patches market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Transdermal Skin Patches Market by Company
Hisamitsu Pharmaceutical
Luye Pharma Group
Mundipharma International
Purdue Pharma
Mylan N.V.
Novartis AG
Johnson & Johnson
Teva Pharmaceutical Industries
Transdermal Skin Patches Segment by Type
Drug in Adhesive
Reservoir
Vapor
Matrix
Others
Transdermal Skin Patches Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Transdermal Skin Patches Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Skin Patches market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transdermal Skin Patches and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Skin Patches.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transdermal Skin Patches manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Transdermal Skin Patches in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Drug in Adhesive
- Reservoir
- Vapor
- Matrix
- Others
Applications
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Companies covered
- Hisamitsu Pharmaceutical
- Luye Pharma Group
- Mundipharma International
- Purdue Pharma
- Mylan N.V.
- Novartis AG
- Johnson & Johnson
- Teva Pharmaceutical Industries
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Transdermal Skin Patches Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Transdermal Skin Patches Sales Estimates and Forecasts (2021-2032)
- 1.3 Transdermal Skin Patches Market by Type
- 1.3.1 Drug in Adhesive
- 1.3.2 Reservoir
- 1.3.3 Vapor
- 1.3.4 Matrix
- 1.3.5 Others
- 1.4 Global Transdermal Skin Patches Market Size by Type
- 1.4.1 Global Transdermal Skin Patches Market Size Overview by Type (2021-2032)
- 1.4.2 Global Transdermal Skin Patches Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Transdermal Skin Patches Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Transdermal Skin Patches Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Transdermal Skin Patches Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Transdermal Skin Patches Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Transdermal Skin Patches Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Transdermal Skin Patches Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Transdermal Skin Patches Industry Trends
- 2.2 Transdermal Skin Patches Industry Drivers
- 2.3 Transdermal Skin Patches Industry Opportunities and Challenges
- 2.4 Transdermal Skin Patches Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Transdermal Skin Patches Revenue (2021-2026)
- 3.2 Global Top Players by Transdermal Skin Patches Sales (2021-2026)
- 3.3 Global Top Players by Transdermal Skin Patches Price (2021-2026)
- 3.4 Global Transdermal Skin Patches Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Transdermal Skin Patches Major Company Production Sites & Headquarters
- 3.6 Global Transdermal Skin Patches Company, Product Type & Application
- 3.7 Global Transdermal Skin Patches Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Transdermal Skin Patches Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Transdermal Skin Patches Players Market Share by Revenue in 2025
- 3.8.3 2025 Transdermal Skin Patches Tier 1, Tier 2, and Tier 3
4 Transdermal Skin Patches Regional Status and Outlook
- 4.1 Global Transdermal Skin Patches Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Transdermal Skin Patches Historic Market Size by Region
- 4.2.1 Global Transdermal Skin Patches Sales in Volume by Region (2021-2026)
- 4.2.2 Global Transdermal Skin Patches Sales in Value by Region (2021-2026)
- 4.2.3 Global Transdermal Skin Patches Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Transdermal Skin Patches Forecasted Market Size by Region
- 4.3.1 Global Transdermal Skin Patches Sales in Volume by Region (2027-2032)
- 4.3.2 Global Transdermal Skin Patches Sales in Value by Region (2027-2032)
- 4.3.3 Global Transdermal Skin Patches Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Transdermal Skin Patches by Application
- 5.1 Transdermal Skin Patches Market by Application
- 5.1.1 Hospital Pharmacies
- 5.1.2 Online Pharmacies
- 5.1.3 Retail Pharmacies
- 5.2 Global Transdermal Skin Patches Market Size by Application
- 5.2.1 Global Transdermal Skin Patches Market Size Overview by Application (2021-2032)
- 5.2.2 Global Transdermal Skin Patches Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Transdermal Skin Patches Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Transdermal Skin Patches Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Transdermal Skin Patches Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Transdermal Skin Patches Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Transdermal Skin Patches Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Transdermal Skin Patches Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Hisamitsu Pharmaceutical
- 6.1.1 Hisamitsu Pharmaceutical Company Information
- 6.1.2 Hisamitsu Pharmaceutical Business Overview
- 6.1.3 Hisamitsu Pharmaceutical Transdermal Skin Patches Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Hisamitsu Pharmaceutical Transdermal Skin Patches Product Portfolio
- 6.1.5 Hisamitsu Pharmaceutical Recent Developments
- 6.2 Luye Pharma Group
- 6.2.1 Luye Pharma Group Company Information
- 6.2.2 Luye Pharma Group Business Overview
- 6.2.3 Luye Pharma Group Transdermal Skin Patches Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Luye Pharma Group Transdermal Skin Patches Product Portfolio
- 6.2.5 Luye Pharma Group Recent Developments
- 6.3 Mundipharma International
- 6.3.1 Mundipharma International Company Information
- 6.3.2 Mundipharma International Business Overview
- 6.3.3 Mundipharma International Transdermal Skin Patches Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Mundipharma International Transdermal Skin Patches Product Portfolio
- 6.3.5 Mundipharma International Recent Developments
- 6.4 Purdue Pharma
- 6.4.1 Purdue Pharma Company Information
- 6.4.2 Purdue Pharma Business Overview
- 6.4.3 Purdue Pharma Transdermal Skin Patches Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Purdue Pharma Transdermal Skin Patches Product Portfolio
- 6.4.5 Purdue Pharma Recent Developments
- 6.5 Mylan N.V.
- 6.5.1 Mylan N.V. Company Information
- 6.5.2 Mylan N.V. Business Overview
- 6.5.3 Mylan N.V. Transdermal Skin Patches Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Mylan N.V. Transdermal Skin Patches Product Portfolio
- 6.5.5 Mylan N.V. Recent Developments
- 6.6 Novartis AG
- 6.6.1 Novartis AG Company Information
- 6.6.2 Novartis AG Business Overview
- 6.6.3 Novartis AG Transdermal Skin Patches Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Novartis AG Transdermal Skin Patches Product Portfolio
- 6.6.5 Novartis AG Recent Developments
- 6.7 Johnson & Johnson
- 6.7.1 Johnson & Johnson Company Information
- 6.7.2 Johnson & Johnson Business Overview
- 6.7.3 Johnson & Johnson Transdermal Skin Patches Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Johnson & Johnson Transdermal Skin Patches Product Portfolio
- 6.7.5 Johnson & Johnson Recent Developments
- 6.8 Teva Pharmaceutical Industries
- 6.8.1 Teva Pharmaceutical Industries Company Information
- 6.8.2 Teva Pharmaceutical Industries Business Overview
- 6.8.3 Teva Pharmaceutical Industries Transdermal Skin Patches Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Teva Pharmaceutical Industries Transdermal Skin Patches Product Portfolio
- 6.8.5 Teva Pharmaceutical Industries Recent Developments
7 North America by Country
- 7.1 North America Transdermal Skin Patches Sales by Country
- 7.1.1 North America Transdermal Skin Patches Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Transdermal Skin Patches Sales by Country (2021-2026)
- 7.1.3 North America Transdermal Skin Patches Sales Forecast by Country (2027-2032)
- 7.2 North America Transdermal Skin Patches Market Size by Country
- 7.2.1 North America Transdermal Skin Patches Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Transdermal Skin Patches Market Size by Country (2021-2026)
- 7.2.3 North America Transdermal Skin Patches Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Transdermal Skin Patches Sales by Country
- 8.1.1 Europe Transdermal Skin Patches Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Transdermal Skin Patches Sales by Country (2021-2026)
- 8.1.3 Europe Transdermal Skin Patches Sales Forecast by Country (2027-2032)
- 8.2 Europe Transdermal Skin Patches Market Size by Country
- 8.2.1 Europe Transdermal Skin Patches Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Transdermal Skin Patches Market Size by Country (2021-2026)
- 8.2.3 Europe Transdermal Skin Patches Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Transdermal Skin Patches Sales by Country
- 9.1.1 Asia-Pacific Transdermal Skin Patches Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Transdermal Skin Patches Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Transdermal Skin Patches Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Transdermal Skin Patches Market Size by Country
- 9.2.1 Asia-Pacific Transdermal Skin Patches Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Transdermal Skin Patches Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Transdermal Skin Patches Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Transdermal Skin Patches Sales by Country
- 10.1.1 South America Transdermal Skin Patches Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Transdermal Skin Patches Sales by Country (2021-2026)
- 10.1.3 South America Transdermal Skin Patches Sales Forecast by Country (2027-2032)
- 10.2 South America Transdermal Skin Patches Market Size by Country
- 10.2.1 South America Transdermal Skin Patches Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Transdermal Skin Patches Market Size by Country (2021-2026)
- 10.2.3 South America Transdermal Skin Patches Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Transdermal Skin Patches Sales by Country
- 11.1.1 Middle East and Africa Transdermal Skin Patches Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Transdermal Skin Patches Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Transdermal Skin Patches Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Transdermal Skin Patches Market Size by Country
- 11.2.1 Middle East and Africa Transdermal Skin Patches Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Transdermal Skin Patches Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Transdermal Skin Patches Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Transdermal Skin Patches Value Chain Analysis
- 12.1.1 Transdermal Skin Patches Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Transdermal Skin Patches Production Mode & Process
- 12.2 Transdermal Skin Patches Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Transdermal Skin Patches Distributors
- 12.2.3 Transdermal Skin Patches Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst